These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 28203072

  • 1. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
    Vogelmeier C, Worth H, Buhl R, Criée CP, Lossi NS, Mailänder C, Kardos P.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
    [Abstract] [Full Text] [Related]

  • 2. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.
    Kaplan AG.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2535-48. PubMed ID: 26648711
    [Abstract] [Full Text] [Related]

  • 3. Withdrawal of Inhaled Corticosteroids from Patients with COPD; Effect on Exacerbation Frequency and Lung Function: A Systematic Review.
    Georgiou A, Ramesh R, Schofield P, White P, Harries TH.
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1403-1419. PubMed ID: 38919905
    [Abstract] [Full Text] [Related]

  • 4. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J, Dik N, Bugden S.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
    [Abstract] [Full Text] [Related]

  • 7. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
    Worth H, Buhl R, Criée CP, Kardos P, Lossi NS, Vogelmeier CF.
    Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, Oh YM, Lee SD, Park YB.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct; 11():2797-2803. PubMed ID: 27877033
    [Abstract] [Full Text] [Related]

  • 11. A year in the life of German patients with COPD: the DACCORD observational study.
    Buhl R, Criée CP, Kardos P, Vogelmeier C, Lossi N, Mailänder C, Worth H.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct; 11():1639-46. PubMed ID: 27499620
    [Abstract] [Full Text] [Related]

  • 12. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.
    Sulku J, Janson C, Melhus H, Malinovschi A, Ställberg B, Bröms K, Högman M, Lisspers K, Hammarlund-Udenaes M, Nielsen EI.
    Int J Chron Obstruct Pulmon Dis; 2019 Oct; 14():2451-2460. PubMed ID: 31806954
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.
    Cheng SL, Wang HH, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct; 12():2231-2238. PubMed ID: 28814851
    [Abstract] [Full Text] [Related]

  • 16. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WM, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct; 9():1163-86. PubMed ID: 25378918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
    Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM.
    Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
    [Abstract] [Full Text] [Related]

  • 19. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB, Rigby A, Morice AH.
    Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
    [Abstract] [Full Text] [Related]

  • 20. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():1093-102. PubMed ID: 26089659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.